@oxxa23
Interesting hey.
I went looking for the label claims and Zydax and Cartrophen are basically the same that they are "an aid in the treatment of non-infectious inflammatory joint disease". This seems pretty vague (nothing about OA, or pain, or function or cartilage or enzymes...just "an aid"). But the marketing material that goes along with it is very explicit about it being DMOAD - maybe they can use a bit of spin because its not specifically on the label.
Nevertheless, check out this 16 page brochure..
http://www.cartrophen.com/wp-content/uploads/2016/07/Cartrophen_Vet_brochure_16-pages.pdf
Plenty of data in it, and they are pretty confident about it being DMOAD given the subtitle on the front page....
Ann: PARADIGM RECEIVES FEEDBACK FROM US FDA ON IND SUBMISSION, page-146
-
- There are more pages in this discussion • 149 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.0¢ |
Change
-0.005(2.13%) |
Mkt cap ! $80.45M | |||
| Open | High | Low | Value | Volume |
| 23.8¢ | 24.0¢ | 23.0¢ | $124.1K | 527.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 32320 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 28026 | 2 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |